Academic Journal

Ruxolitinib in Patients With Chronic Graft-Versus-Host Disease: 3-Year Final Analysis of Efficacy and Safety From the Phase III REACH3 Study

التفاصيل البيبلوغرافية
العنوان: Ruxolitinib in Patients With Chronic Graft-Versus-Host Disease: 3-Year Final Analysis of Efficacy and Safety From the Phase III REACH3 Study
المؤلفون: Zeiser, Robert, Russo, Domenico, Ram, Ron, Hashmi, Shahrukh K., Chakraverty, Ronjon, Middeke, Jan-Moritz, Musso, Maurizio, Giebel, Sebastian, Uzay, Ant, Langmuir, Peter, Li, Xuechan, Hamad, Nada, Gowda, Maanasa, Stefanelli, Tommaso, Lee, Stephanie J, Teshima, Takanori, Locatelli, Franco
المصدر: Blood. - 142, Supplement 1 (2023) , 654-654, ISSN: 1528-0020
سنة النشر: 2023
المجموعة: University of Freiburg: FreiDok
نوع الوثيقة: article in journal/newspaper
اللغة: English
Relation: https://freidok.uni-freiburg.de/data/254460
DOI: 10.1182/blood-2023-172590
الاتاحة: https://freidok.uni-freiburg.de/data/254460
https://doi.org/10.1182/blood-2023-172590
رقم الانضمام: edsbas.F90E419A
قاعدة البيانات: BASE
الوصف
DOI:10.1182/blood-2023-172590